期刊文献+

新疆地区43例淋巴母细胞淋巴瘤的病理及临床特征分析

Clinical characteristics and prognosis of 43 patients with lymphoblastic lymphoma in Xinjiang region of China
下载PDF
导出
摘要 目的探讨新疆地区汉族和维吾尔族淋巴母细胞淋巴瘤(lymphoblastic lymphoma,LBL)患者的病理及临床特征。方法回顾性分析新疆医科大学附属肿瘤医院2003年1月-2011年12月收治的43例汉族和维吾尔族I。BI.患者的病理及临床资料,治疗方案包括CHOP、CHOP样方案、改良的Hyper—CVAD、BFM方案及自体干细胞移植(autologous stem cell transplantation,ASCT)。采用Kaplan-Meier法进行生存分析,Cox比例风险模型分析影响预后的因素。结果全组患者中位随访时间11个月(4~66个月),CR15例,PR9例,PD19例。生存22例,死亡21例,死亡的原因主要为疾病进展或复发(1例死于感染)。1年、2年的总体生存率分别为55%、45%。单因素分析显示,体力状态(performance status,PS)评分、B症状、大纵隔或大肿块、骨髓受侵、脑脊液异常、LDH水平、治疗方式及疗效与LBL患者的预后相关(P<0.05)。多因素分析显示,LDH水平、治疗方式的选择及疗效评价是新疆地区汉族及维吾尔族LBL患者的独立预后因素(P<0.05)。结论新疆地区LBL多发生于儿童与青少年,绝大多数为TLBL,总体生存率较低,采用改良的BFM方案或Hyper—CVAD方案可改善LBL患者预后。 Objective To investigate the clinical characteristics and prognostic factors of patients with lymphoblastie lymphoma (LBL). Methods Records of 43 Patients with LBL (39 T-LBL and 4 B-LBL) treated from Jan. 2003 to Dec. 2011 in Tumor Hospital, Xinjiang Medical University, were retrospectively analyzed. The patients were treated with CHOP, modified BFM-90 protocol, Hyper-CVAD regimes, and high-dose chemotherapy (HDC)/autologous stem cell transplantation(ASCT). Kaplan-Meier method was used for survival analysis and Cox regression model for multivariate analysis. Results 30 patients were male and 13 female. The median age at diagnosis was 13 years (ranged from 5 years to 46). 38 cases (88. 3%) were in stage Ⅲ or Ⅳ at diagnosis. 22 cases(51.2%) had mediastinal masses. The response rate (RR) for the whole group was 55.8%, complete remission (CR) rate 34.9%. With a median follow-up duration of 11 months (range 4--66 months), The 1--year and 2--year overall survival (OS) rates were 55% and45% respectively. In univariate analysis, performance status (PS), B symptoms, mediastinal masses, involved bone marrow, central nervous system (CNS) involvement, serum lactate dehydrogenase (LDH) levels, choice of therapy modality and achievement of remission were statistically significantly correlated to the prognosis. In univariate analysis, elevated LDH level, choice of therapy modality and achievement of remission were statistically significant prognostic factors. Conclusion LBL is more common in children and adolescents and has poor prognosis in Xinjiang region. Modified BFM 90 protocol and Hyper-CVAD regimes can improve the efficacy and survival of LBL.
出处 《新疆医科大学学报》 CAS 2014年第4期450-453,457,共5页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区自然科学基金(2012211A045)
关键词 淋巴母细胞淋巴瘤 化学治疗 预后 生存 lymphoblastic lymphoma chemotherapy prognosis survival
  • 相关文献

参考文献13

  • 1Portell CA, Sweetenham JW. Adult lymphoblastic lymphoma [J].Cancer J, 2012,18(5): 432-438.
  • 2沈志祥,朱雄增.恶性淋巴瘤[M].2版.北京:人民卫生出版社.2011:952-959.
  • 3Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. Eur J Cancer, 2009,45(2) :228-247.
  • 4孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2011:135-146.
  • 5潘云,李甘地,刘卫平,张文燕,唐源,李俸媛.淋巴母细胞淋巴瘤/白血病临床病理、免疫表型及预后相关性研究[J].中华病理学杂志,2009,38(12):810-815. 被引量:12
  • 6Cortelazzo S, Ponzoni M, Ferreri AJ, et al. Lymphoblastic lym- phoma[J]. Crit Rev Oncol Hematol, 2011,79 (3) : 330-343.
  • 7施薇,石远凯,何小慧,周生余,董梅,张长弓,杨建良,刘鹏,秦燕,杨晟,桂琳.改良Hyper-CVAD方案治疗前体淋巴母细胞淋巴瘤患者的临床分析[J].中华医学杂志,2010,90(14):978-981. 被引量:14
  • 8Kang W, Hahn JS, Kim JS, et al. Nine-year survival of lym- phoblasticlymphoma patients . Yonsei Med J, 2006, 47 (4) :466-474.
  • 9Sun XF, Xia ZJ, Zhen ZJ, et al. Intensive chemotherapy im- proved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma[J]. Int J Clin Oncol, 2008 , 13 (5) :436-441.
  • 10Song KW, Barnett MJ, Gascoyne RD, et al.Primary therapy for adults with T cell lymphoblastic lymphoma with hemato- poietic stem cell transplantation results in favorable outcomes . Ann Oncol, 2007 ,18(3):535-540.

二级参考文献41

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2潘云,刘卫平,李金范,张文燕,李俸媛,陆晓茜,李丹,李甘地.96例淋巴母细胞淋巴瘤临床病理分析[J].中华血液学杂志,2005,26(4):218-222. 被引量:23
  • 3李甘地.儿童常见淋巴造血系统肿瘤的诊断和鉴别诊断[J].中华病理学杂志,2005,34(12):765-768. 被引量:3
  • 4孙晓非,甄子俊,刘冬耕,夏忠军,黄慧强,张力,周中梅,李宇红,夏奕,凌家瑜,管忠震.改良BFM-90方案明显改善儿童青少年淋巴母细胞型淋巴瘤的疗效[J].中华肿瘤杂志,2007,29(1):58-61. 被引量:12
  • 5Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press,2001.
  • 6Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.
  • 7Miller TP, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood, 1994,83:1460-1466.
  • 8Feller AC, Diebold J. Histopathology of nodal and extranodal non-Hodgkin's lymphomas: based on the WHO classification. 3rd ed. Berlin: Springer-Verlag, 2004.
  • 9Onciu M, Lorsbach RB, Henry EC, et al. Terminal Deoxynucleotidyl transferase-pasitive lymphoid cells in reactive lymph nodes from children with malignant tumors. Am J Clin Pathol,2002,118:248-254.
  • 10Suzimiya J, Ohshima K, Kikuchi M, et al. Terminal deoxynuceotidyl transferase staining of malignant lymphomas in paraffin sections : a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol, 1997,182:86.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部